Hilo de navegación
Investigación traslacional en oncología hepática
Publicaciones destacadas
-
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
Llovet, JM; Willoughby, CE; Singal, AG; Greten, TF; Heikenwälder, M;El-Serag, HB; Finn, RS; Friedman, SL.Referencia:Nature Reviews Gastroenterology & Hepatology 2023.
-
International Liver cancer Association (ILCA) White Paper on Hepatocellular carcinoma Risk Stratification and Surveillance
Singal, AG; Sanduzzi-Zamparelli, M; Nahon, P; Ronot, M; Hoshida, Y;(...)Vilgrain, V; Marrero, J; Llovet, JM; Parikh, ND; Villanueva, A.Referencia:Journal Of Hepatology 2023.
-
Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma
Haber, Philipp K; Castet, Florian; Torres-Martin, Miguel; Andreu-Oller, Carmen; Puigvehi, Marc;(...)Finn, Richard S; Thung, Swan; Villanueva, Augusto; Sia, Daniela; Llovet, Josep M.Referencia:Gastroenterology 2023.
-
Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification
Montironi, C; Castet, F; Haber, PK; Pinyol, R; Torres-Martin, M;(...)Villanueva, A; Friedman, SL; Uzilov, A; Sia, D; Llovet, JM.Referencia:Gut 2023.
-
Immunotherapies for hepatocellular carcinoma
Llovet, JM; Castet, F; Heikenwalder, M; Maini, MK; Mazzaferro, V;Pinato, DJ; Pikarsky, E; Zhu, AX; Finn, RS.Referencia:Nature Reviews Clinical Oncology 2022.
-
Molecular characterization of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
Pinyol, R; Torrecilla, S; Wang, H; Montironi, C; Piqué-Gili, M;(...)Heikenwalder, M; Sanyal, A; Friedman, SL; Sia, D; Llovet, JM.Referencia:Journal Of Hepatology 2021.
-
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Pfister, D; Núñez, NG; Pinyol, R; Govaere, O; Pinter, M;(...)Amit, I; Knolle, P; Becher, B; Llovet, JM; Heikenwalder, M.Referencia:Nature 2021.
-
Hepatocellular carcinoma
Llovet, JM; Kelley, RK; Villanueva, A; Singal, AG; Pikarsky, E;Roayaie, S; Lencioni, R; Koike, K; Zucman-Rossi, J; Finn, RS.Referencia:Nature Reviews Disease Primers 2021.
-
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
Hoshida, Yujin; Villanueva, Augusto; Kobayashi, Masahiro; Peix, Judit; Chiang, Derek Y;(...)Bruix, Jordi; Friedman, Scott L; Kumada, Hiromitsu; Llovet, Josep M; Golub, Todd R.Referencia:New England Journal Of Medicine 2008.
-
Sorafenib in advanced hepatocellular carcinoma
Llovet, Josep M; Ricci, Sergio; Mazzaferro, Vincenzo; Hilgard, Philip; Gane, Edward;(...)Borbath, Ivan; Haussinger, Dieter; Giannaris, Tom; Moscovici, Marius; Bruix, Jordi.Referencia:New England Journal Of Medicine 2008.
